ObsEva to Increase Issued Share Capital by Creating Additional Treasury Shares
14 avr. 2020 01h00 HE
|
ObsEva SA
Geneva, Switzerland and Boston, MA – Tuesday 14, 2020 – ObsEva SA (NASDAQ: OBSV / SIX: OBSN), a Swiss clinical-stage biopharmaceutical company focused on the development and commercialization of...
Marel - Hækkun hlutafjár
28 juin 2019 08h30 HE
|
Marel hf.
Samkvæmt 84. gr. laga um verðbréfaviðskipti nr. 108/2007 skal útgefandi, ef hann hækkar eða lækkar hlutafé sitt eða fjölgar eða fækkar atkvæðum, á síðasta viðskiptadegi þess mánaðar er breytingarnar...
Marel - Increase of share capital
28 juin 2019 08h30 HE
|
Marel hf.
According to Article 84 of Act No. 108/2007 on Securities transactions, when an issuer increases or reduces its share capital or number of voting rights, the issuer shall on the last trading day of...
Marel - Lækkun hlutafjár
29 mars 2019 09h30 HE
|
Marel hf.
Samkvæmt 84. gr. laga um verðbréfaviðskipti nr. 108/2007 skal útgefandi, ef hann hækkar eða lækkar hlutafé sitt eða fjölgar eða fækkar atkvæðum, á síðasta viðskiptadegi þess mánaðar er breytingarnar...
Marel - Reduction of share capital
29 mars 2019 09h30 HE
|
Marel hf.
According to Article 84 of Act No. 108/2007 on Securities transactions, when an issuer increases or reduces its share capital or number of voting rights, the issuer shall on the last trading day of...
Publication of ObsEva SA Invitation to 2019 Annual General Meeting of Shareholders
29 mars 2019 02h00 HE
|
ObsEva SA
Geneva, Switzerland and Boston, MA – March 29, 2019 - ObsEva SA (NASDAQ: OBSV / SIX: OBSN), a clinical-stage biopharmaceutical company focused on the development and commercialization of novel...